Integra LifeSciences Holdings Corporation
IART · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $2 | $2 | $2 |
| Enterprise Value | $1 | $3 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.3% | 8.6% | -13.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.2% | 50.4% | 50.8% | 56.3% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 13.4% | -113.6% | 6.8% | 17.9% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -1.3% | -116.5% | -6.6% | 4.4% |
| EPS Diluted | -0.07 | -6.33 | -0.33 | 0.25 |
| % Growth | 98.9% | -1,818.2% | -232% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |